Safety and Efficacy of Drug Combinations Against Schistosomiasis

NCT01050374 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

650

Enrollment

OTHER

Sponsor class

Conditions

Parasitic Diseases

Interventions

DRUG: albendazole + praziquantel
DRUG: mebendazole + praziquantel

Sponsor

DBL -Institute for Health Research and Development